Pulmonary atresia medical therapy
|
Pulmonary atresia Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Pulmonary atresia medical therapy On the Web |
|
American Roentgen Ray Society Images of Pulmonary atresia medical therapy |
|
Risk calculators and risk factors for Pulmonary atresia medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2], Cafer Zorkun, M.D., Ph.D. [3]; Assistant Editor(s)-In-Chief: Kristin Feeney, B.S. [4]
Overview
A patient with pulmonary atresia will require immediate intervention. Intravenous medical therapies may be employed as a supportive mechanism to assist in improvement of hemodynamics, as well as cardiovascular and pulmonary functioning.
Medical Therapy
- Medical therapy in new born with Pulmonary atresia serves only as a bridge to the surgical treatment. It is temporarily and definitive treatment is only surgical
- It is targeted to keep the ductus arteriosus open that otherwise will close in 48 hr. An IV medication called prostaglandin E1 is used for to keep the ductus arteriosus open and gives time while the new born will be prepared for the definitive treatment. Blood circulates from the aorta to the pulmonary artery via this ductus and get oxygenated in the lungs.